ReposiTrak (TRAK) stock price is $7.17, down 0.42% on the day, as of Oct 19, 2026. It has a market cap of $130.84Mn and a P/E ratio of 18.23, and is classified in the Supply Chain Software industry (Technology sector).
Enterprise Value
Margins
P/FCF
Key Stats
Market Cap130.84 Mn
P/E18.23
P/S5.78
Div. Yield0.00
Total Debt (Qtr)294,340.00
Add ratio to table…
About
ReposiTrak, Inc. is a Software as a Service provider that operates a business to business e commerce, compliance and traceability, and supply chain management platform. The platform is delivered via a cloud based infrastructure that allows real-time data exchange between trading partners. The company uses a hub and spoke model where it is engaged by retailers and wholesalers who then require their suppliers to use the platform. Its solution helps customers manage programs…
ReposiTrak, Inc. is a Software as a Service provider that operates a business to business e commerce, compliance and traceability, and supply chain management platform. The platform is delivered via a cloud based infrastructure that allows real-time data exchange between trading partners. The company uses a hub and spoke model where it is engaged by retailers and wholesalers who then require their suppliers to use the platform. Its solution helps customers manage programs such as out of stock management and scan based trading, reduce supply chain risk through compliance documentation, ensure traceability per regulatory requirements, and improve product ordering and forecasting to accelerate sales and enhance supply chain efficiencies.
The company generates revenue primarily through recurring subscription fees for access to its compliance, traceability and supply chain solutions, and through fees for consulting, implementation and support services. Customers pay based on the number of connected trading partners and the level of usage of the platform. The Company has been awarded nine U. S. patents and maintains two professional services groups: the Business Analytics Group and the Professional Services Group.
The company operates through the following segments.
Compliance: The Compliance segment helps customers vet suppliers and reduce regulatory, legal and criminal risk by ensuring adherence to food safety regulations such as the Food Safety Modernization Act.
Traceability: The Traceability segment, also known as the ReposiTrak Traceability Network, enables capture and sharing of key data elements required by Section 204(d) of the Food Safety Modernization Act to support farm to shelf traceability.
Supply Chain: The Supply Chain segment assists customers in managing supplier relationships, enabling faster onboarding of new suppliers, improving sourcing flexibility and reducing working capital, labor costs and waste.
ReposiTrak competes with larger software vendors, B2B exchanges, consulting firms and focused solution providers, but differentiates itself through deep industry knowledge, a broad suite of offerings, long standing relationships with industry associations and trade groups, and a portfolio of nine U. S. patents. The hub and spoke model allows the firm to serve both large retailers and thousands of supplier partners. Its traceability network is described as the largest connected network of food suppliers, wholesalers and retailers in the world, enabling end to end traceability that supports a safer food supply chain and faster recall responses. The Business Analytics Group offers business consulting services to suppliers and retailers in the grocery, convenience store and specialty retail industries, while the Professional Services Group focuses on implementation and integration support.
The company serves multi store food retail chains, restaurants, branded food manufacturers, food wholesalers and distributors, and other food service businesses. Its customers are primarily located in the United States consumer retail sector for food, convenience stores and general merchandise, although the solutions are also applicable to a variety of other industries domestically and abroad. As of June 30, 2025, the Company employed 69 people, with 20 based overseas, and it connects thousands of supplier locations to thousands of retailer locations through its hub and spoke network. The platform also provides analytics and reporting tools that help customers monitor compliance status and traceability data in real time.
Sector:TechnologySector rationaleReposiTrak is primarily a Software as a Service (SaaS) provider that sells a cloud-based supply chain management, compliance, and traceability platform, generating revenue through recurring subscription fees. This fits the Technology sector's 'Supply Chain Software' and 'Cloud Platforms' industries. A secondary sector of Industrials is justified because the company maintains two professional services groups that provide business consulting and implementation services to its customers.Industries:Supply Chain SoftwareSupply Chain SoftwarePrimaryReposiTrak provides a supply chain management platform that assists customers in managing supplier relationships, improving sourcing flexibility, and reducing waste. Its core functionality focuses on the movement and management of goods between food manufacturers, wholesalers, and retailers.Compliance SoftwareCompliance SoftwareSecondaryThe company has a dedicated Compliance segment that helps customers vet suppliers and ensure adherence to food safety regulations, specifically citing the Food Safety Modernization Act.IT ServicesIT ServicesSecondaryThe company generates revenue through fees for consulting, implementation, and support services provided by its Business Analytics Group and Professional Services Group.Classified using BQ-MICSCIK: 0000050471
Bull & bear
Investment Thesis
▲ Bull case
ReposiTrak's transition to a recurring SaaS model has created a structurally superior revenue base with over 98% of total revenue now recurring, fundamentally transforming business predictability and margin sustainability. This shift, achieved by converting more than $7 million of historical one-time revenue while eliminating low-margin legacy streams, has driven operating expenses down from $19 million to $16 million annually despite inflationary pressures, enabling net margin expansion from 8% to above 30%. The company's $26.4 million cash balance and zero bank debt provide exceptional flexibility to fund growth initiatives without dilution, while the 16% annual compound growth in net cash since fiscal 2020 demonstrates consistent capital generation. Critically, the elimination of net operating loss carryforwards has normalized the effective tax rate to 18-20%, removing a historical earnings boost and revealing true underlying profitability that is now expanding through operating leverage in the scalable SaaS platform.
The Touchless Traceability™ solution represents a first-mover regulatory moat with near-term revenue acceleration potential masked by implementation lags. Two major customers—a leading grocery retailer and a leading Southern wholesale cooperative—have already achieved full end-to-end deployment, proving scalability and regulatory readiness for FSMA 204 compliance. Management explicitly noted that traceability revenue recognition lags due to significant onboarding time before recurring revenue begins, meaning current financials understate the pipeline of contracted implementations. The recent news of additional snack food suppliers joining the onboarding queue for RTN, including providers of nuts, olives, and dried fruit, indicates broadening adoption beyond initial pilot segments. With the FDA's FSMA 204 deadline extension having temporarily suppressed 2025-onboarding activity (which had previously boosted Q3 FY25 revenue by 16%), the resumption of normalized onboarding trends positions the company for accelerated revenue recognition as these implementations mature, creating a hidden catalyst not reflected in flat quarterly revenue comparisons.
The SPAR Group collaboration transforms ReposiTrak from a diagnostic provider into an end-to-end supply chain remediation partner, addressing the critical industry gap between problem identification and physical resolution—a vulnerability AI tools cannot solve. Fields emphasized that while AI can flag out-of-stocks or recalls, it cannot restock shelves or retrieve products, making human execution essential. The partnership leverages ReposiTrak's proprietary AI-driven issue detection (which uniquely identifies incorrect supplier data at 50-70% error rates) with SPAR's field teams to enable in-store remediation, creating a defensible moat against pure-play AI competitors. Early customer interest from a global CPG drug company suggests potential for material scale within six to nine months, with Fields stating a deal at this level would "not be a $50 thousand a year deal" but substantial. This initiative aligns with the company's platform expansion vision from intelligence to operational execution, opening new revenue streams in merchandising support and retail execution that complement its core traceability business.
ReposiTrak's transition to a recurring SaaS model has created a structurally superior revenue base with over 98% of total revenue now recurring, fundamentally transforming business predictability and margin sustainability. This shift, achieved by converting more than $7 million of historical one-time revenue while eliminating low-margin legacy streams, has driven operating expenses down from $19 million to $16 million annually despite inflationary pressures, enabling net margin expansion from 8% to above 30%. The company's $26.4 million cash balance and zero bank debt provide exceptional flexibility to fund growth initiatives without dilution, while the 16% annual compound growth in net cash since fiscal 2020 demonstrates consistent capital generation. Critically, the elimination of net operating loss carryforwards has normalized the effective tax rate to 18-20%, removing a historical earnings boost and revealing true underlying profitability that is now expanding through operating leverage in the scalable SaaS platform.
The Touchless Traceability™ solution represents a first-mover regulatory moat with near-term revenue acceleration potential masked by implementation lags. Two major customers—a leading grocery retailer and a leading Southern wholesale cooperative—have already achieved full end-to-end deployment, proving scalability and regulatory readiness for FSMA 204 compliance. Management explicitly noted that traceability revenue recognition lags due to significant onboarding time before recurring revenue begins, meaning current financials understate the pipeline of contracted implementations. The recent news of additional snack food suppliers joining the onboarding queue for RTN, including providers of nuts, olives, and dried fruit, indicates broadening adoption beyond initial pilot segments. With the FDA's FSMA 204 deadline extension having temporarily suppressed 2025-onboarding activity (which had previously boosted Q3 FY25 revenue by 16%), the resumption of normalized onboarding trends positions the company for accelerated revenue recognition as these implementations mature, creating a hidden catalyst not reflected in flat quarterly revenue comparisons.
The SPAR Group collaboration transforms ReposiTrak from a diagnostic provider into an end-to-end supply chain remediation partner, addressing the critical industry gap between problem identification and physical resolution—a vulnerability AI tools cannot solve. Fields emphasized that while AI can flag out-of-stocks or recalls, it cannot restock shelves or retrieve products, making human execution essential. The partnership leverages ReposiTrak's proprietary AI-driven issue detection (which uniquely identifies incorrect supplier data at 50-70% error rates) with SPAR's field teams to enable in-store remediation, creating a defensible moat against pure-play AI competitors. Early customer interest from a global CPG drug company suggests potential for material scale within six to nine months, with Fields stating a deal at this level would "not be a $50 thousand a year deal" but substantial. This initiative aligns with the company's platform expansion vision from intelligence to operational execution, opening new revenue streams in merchandising support and retail execution that complement its core traceability business.
ReposiTrak's flat quarterly revenue and decelerating year-to-date growth (5% YTD vs. prior period) signal potential saturation in its core traceability market, with management attributing the Q3 flatness solely to the FSMA 204 deadline extension suppressing 2025-onboarding activity—a temporary factor that may not fully explain the lack of sequential momentum. The company's reliance on regulatory-driven adoption creates execution risk; if retailers and wholesalers delay compliance investments beyond current expectations, or if alternative lower-cost traceability solutions emerge, the projected revenue recognition lag could extend indefinitely, leaving near-term growth dependent on uncertain timing of customer implementations. Furthermore, the high error rates in supplier data (50-70%) that the AI system corrects reveal a fundamental data quality issue in the supply chain ecosystem; if suppliers fail to improve data integrity over time, the ongoing need for correction could strain the scalability of the Touchless Traceability™ model, potentially increasing support costs contrary to management's assertion of no meaningful expense increase from AI initiatives.
The SPAR Group partnership, while strategically compelling, faces significant execution and monetization risks that management underemphasized during the call. Fields acknowledged it is "too early" to see KPIs and projected financial impact in 6-9 months, yet provided no concrete milestones, pilot revenue figures, or customer commitment levels to validate the early-stage collaboration. The reliance on a single large CPG drug company as a potential flagship deal introduces concentration risk—if this prospect does not materialize, the partnership may remain confined to smaller, less scalable engagements. Additionally, SPAR's field execution model introduces variable labor costs and geographic scalability constraints that could erode margins; unlike ReposiTrak's pure SaaS model, this collaboration requires managing third-party service teams, potentially increasing operating complexity and cash operating expenses beyond current guidance, especially if remediation demands spike during peak retail seasons or recall events.
Despite strong net margin expansion to above 30%, the company's profitability is increasingly sensitive to tax rate normalization and shareholder return pressure, with limited room for further operational efficiency gains. The effective tax rate has risen from historical benefits (via NOL carryforwards) to a modeled 20%, eliminating a key driver of past net income growth. Simultaneously, the board authorized $6 million in remaining repurchase capacity and management reiterated immediate retirement of all repurchased shares, signaling a commitment to shareholder returns that could constrain reinvestment in growth initiatives. With annual operating expenses already reduced to $16 million (from $19 million in FY20) and capital expenditures minimal, further margin expansion may require disproportionate investment in sales and general administrative functions—evidenced by YTD SG&A rising 2% to $8.7 million—to chase new market opportunities like the SPAR collaboration, risking margin dilution if these initiatives fail to scale profitably. The flat quarterly revenue also raises concerns about the durability of the SaaS model's operating leverage in a potentially maturing market.
ReposiTrak's flat quarterly revenue and decelerating year-to-date growth (5% YTD vs. prior period) signal potential saturation in its core traceability market, with management attributing the Q3 flatness solely to the FSMA 204 deadline extension suppressing 2025-onboarding activity—a temporary factor that may not fully explain the lack of sequential momentum. The company's reliance on regulatory-driven adoption creates execution risk; if retailers and wholesalers delay compliance investments beyond current expectations, or if alternative lower-cost traceability solutions emerge, the projected revenue recognition lag could extend indefinitely, leaving near-term growth dependent on uncertain timing of customer implementations. Furthermore, the high error rates in supplier data (50-70%) that the AI system corrects reveal a fundamental data quality issue in the supply chain ecosystem; if suppliers fail to improve data integrity over time, the ongoing need for correction could strain the scalability of the Touchless Traceability™ model, potentially increasing support costs contrary to management's assertion of no meaningful expense increase from AI initiatives.
The SPAR Group partnership, while strategically compelling, faces significant execution and monetization risks that management underemphasized during the call. Fields acknowledged it is "too early" to see KPIs and projected financial impact in 6-9 months, yet provided no concrete milestones, pilot revenue figures, or customer commitment levels to validate the early-stage collaboration. The reliance on a single large CPG drug company as a potential flagship deal introduces concentration risk—if this prospect does not materialize, the partnership may remain confined to smaller, less scalable engagements. Additionally, SPAR's field execution model introduces variable labor costs and geographic scalability constraints that could erode margins; unlike ReposiTrak's pure SaaS model, this collaboration requires managing third-party service teams, potentially increasing operating complexity and cash operating expenses beyond current guidance, especially if remediation demands spike during peak retail seasons or recall events.
Despite strong net margin expansion to above 30%, the company's profitability is increasingly sensitive to tax rate normalization and shareholder return pressure, with limited room for further operational efficiency gains. The effective tax rate has risen from historical benefits (via NOL carryforwards) to a modeled 20%, eliminating a key driver of past net income growth. Simultaneously, the board authorized $6 million in remaining repurchase capacity and management reiterated immediate retirement of all repurchased shares, signaling a commitment to shareholder returns that could constrain reinvestment in growth initiatives. With annual operating expenses already reduced to $16 million (from $19 million in FY20) and capital expenditures minimal, further margin expansion may require disproportionate investment in sales and general administrative functions—evidenced by YTD SG&A rising 2% to $8.7 million—to chase new market opportunities like the SPAR collaboration, risking margin dilution if these initiatives fail to scale profitably. The flat quarterly revenue also raises concerns about the durability of the SaaS model's operating leverage in a potentially maturing market.